)

Vicore Pharma (VICO) investor relations material
Vicore Pharma Morgan Stanley 23rd Annual Global Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Company overview and scientific focus
Focuses on the angiotensin II pathway, specifically targeting the AT2 receptor for fibrotic and inflammatory diseases.
Lead indication is idiopathic pulmonary fibrosis (IPF), a disease with high unmet need and significant commercial potential.
Lead compound has completed phase I and IIA trials, with a large phase IIB trial ongoing.
Mechanism of action and differentiation
AT2 receptor activation promotes anti-fibrotic, anti-inflammatory, and vasodilatory effects, supporting tissue repair.
Approach aims to regenerate lung tissue by stimulating alveolar epithelial type II cells, addressing both fibrosis and vascular dysfunction.
Differentiates from existing therapies by targeting epithelial repair and vascular components, not just fibrotic buildup.
Market landscape and treatment challenges
Only two approved IPF drugs exist, both with poor tolerability and limited efficacy, leading to low treatment rates and short duration on therapy.
IPF market is valued at $4 billion and expected to grow, with significant opportunity for better-tolerated, more effective treatments.
Recent phase III successes set a new efficacy bar, but more therapies and combination approaches are needed.
Next Vicore Pharma earnings date

Next Vicore Pharma earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage